scholarly journals Phase II Clinical Trial Evaluating the Standardization of CD3+ T-Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplants (PBSCT) from Matched Related Donors

2020 ◽  
Vol 26 (3) ◽  
pp. S178
Author(s):  
Susan Bal ◽  
Omer Jamy ◽  
Emily Plews ◽  
Ravi Bhatia ◽  
Lawrence Lamb ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Stem Cell ◽  
T Cell ◽  
Phase Ii ◽  
Peripheral Blood ◽  
Peripheral Blood Stem Cell ◽  
Blood Stem Cell ◽  
Phase Ii Clinical Trial ◽  
Cell Dose ◽  
Cell Transplants

scholarly journals A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis

Cancer ◽  
2004 ◽  
Vol 101 (1) ◽  
pp. 156-163 ◽  
Author(s):  
Shreyaskumar R. Patel ◽  
Nicholas Papadopolous ◽  
A. Kevin Raymond ◽  
Michele Donato ◽  
Chu-Myong Seong ◽  
...  
Keyword(s):  
Stem Cell ◽  
Phase Ii ◽  
Peripheral Blood ◽  
Poor Prognosis ◽  
Bone Tumors ◽  
Peripheral Blood Stem Cell ◽  
Phase Ii Study ◽  
Blood Stem Cell ◽  
Stem Cell Support ◽  
Cell Support

scholarly journals Peripheral blood stem cell transplants do not result in endometrial stromal engraftment

2013 ◽  
Vol 99 (2) ◽  
pp. 526-532.e2 ◽  
Author(s):  
Erin F. Wolff ◽  
Naoya Uchida ◽  
Robert E. Donahue ◽  
Mark E. Metzger ◽  
Matthew M. Hsieh ◽  
...  
Keyword(s):  
Stem Cell ◽  
Peripheral Blood ◽  
Peripheral Blood Stem Cell ◽  
Blood Stem Cell ◽  
Cell Transplants ◽  
Stem Cell Transplants
Sign in / Sign up

Export Citation Format

Share Document